New advances in the treatment of Clostridium difficile infection (CDI)
Dennis D Hedge, Joe D Strain, Jodi R Heins, Debra K FarverSouth Dakota State University College of Pharmacy, Brookings, SD 57007, USAAbstract: Clostridium difficile infections (CDI) have increased in frequency throughout the world. In addition to an increase in frequency, recent CDI epidemics have b...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2008-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_4e89e9c79b614328818305ccab07781c | ||
042 | |a dc | ||
100 | 1 | 0 | |a Dennis D Hedge |e author |
700 | 1 | 0 | |a Joe D Strain |e author |
700 | 1 | 0 | |a Jodi R Heins |e author |
700 | 1 | 0 | |a Debra K Farver |e author |
245 | 0 | 0 | |a New advances in the treatment of Clostridium difficile infection (CDI) |
260 | |b Dove Medical Press, |c 2008-09-01T00:00:00Z. | ||
500 | |a 1176-6336 | ||
500 | |a 1178-203X | ||
520 | |a Dennis D Hedge, Joe D Strain, Jodi R Heins, Debra K FarverSouth Dakota State University College of Pharmacy, Brookings, SD 57007, USAAbstract: Clostridium difficile infections (CDI) have increased in frequency throughout the world. In addition to an increase in frequency, recent CDI epidemics have been linked to a hypervirulent C. difficile strain resulting in greater severity of disease. Although most mild to moderate cases of CDI continue to respond to metronidazole or vancomycin, refractory and recurrent cases of CDI may require alternative therapies. This review provides a brief overview of CDI and summarizes studies involving alternative antibiotics, toxin binders, probiotics, and immunological therapies that can be considered for treatment of acute and recurrent CDI in severe and refractory situations.Keywords: Clostridium difficile, antibiotics, probiotics, immunological therapy | ||
546 | |a EN | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Therapeutics and Clinical Risk Management, Vol 2008, Iss Issue 5, Pp 949-964 (2008) | |
787 | 0 | |n http://www.dovepress.com/new-advances-in-the-treatment-of-emclostridium-difficileem-infection-c-a2246 | |
787 | 0 | |n https://doaj.org/toc/1176-6336 | |
787 | 0 | |n https://doaj.org/toc/1178-203X | |
856 | 4 | 1 | |u https://doaj.org/article/4e89e9c79b614328818305ccab07781c |z Connect to this object online. |